Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
02
Obesity, not the amount of radiation given, is the greatest factor in whether early-stage lung cancer patients develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, with obese patients being more than twice as likely to develop chronic pain compared to those who have less body weight, according to a first-of-its-kind study presented Tuesday, November 3, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
U.S. researchers have found that hepatitis B does not increase the risk for pancreatic cancer, a conclusion contradicting a previous study that found a link between the two. The new study by researchers at Henry Ford Hospital was presented at the on-going annual meeting of the American Association for the Study of Liver Diseases in Boston.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO).
31
Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you. Who says? None other than Harvard Medical School. Once considered questionable for your health, it turns out that the beloved beverage is actually healthful in moderation. That means a few cups a day.
30
Canadian researchers say aerobic exercise benefits lymphoma patients -- even those on chemotherapy. The study, published in the Journal of Clinical Oncology, finds lymphoma patients who received exercise intervention reported significantly improved physical functioning, overall improved quality of life, less fatigue, increased happiness, less depression and an improvement in lean body mass.
Researchers link hormone to creation of gene fusion in prostate cancer. Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop.
We care about your feedback. Let us know how we can improve your CancerCompass experience.